Literature DB >> 10490568

Survival and complication free survival in Marfan's syndrome: implications of current guidelines.

M Groenink1, T A Lohuis, J G Tijssen, M S Naeff, R C Hennekam, E E van der Wall, B J Mulder.   

Abstract

OBJECTIVE: To evaluate survival and complication free survival in patients with Marfan's syndrome and to assess the possible influence of recently revised guidelines for prophylactic aortic root replacement in these patients.
METHODS: 130 patients who had been attending one institution over 14 years were evaluated. Kaplan-Meier analysis was performed in 125 patients who did not present with aortic root dissection as the first sign of Marfan's syndrome, with the end points: death, aortic root dissection, and prophylactic aortic root replacement after diagnosis. In the patients developing aortic root dissection, current guidelines for prophylactic aortic root replacement were retrospectively applied to investigate the number of dissections that could theoretically have been prevented. The guidelines were: (1) aortic root diameter >/= 55 mm, (2) positive family history of aortic dissections and aortic root diameter >/= 50 mm, and (3) aortic root growth >/= 2 mm/year. Outcomes following emergency surgery (15 patients) and prophylactic surgery of the aortic root (30 patients) were compared.
RESULTS: Five and 10 year survival after diagnosis was 95% and 88%, and the five and 10 year complication free survival was 78% and 66%, respectively. Thirteen patients developed dissection, 30 underwent prophylactic repair, and 82 had an uncomplicated course. Eleven dissections could theoretically have been prevented by application of the current guidelines. Five year survival following emergency and prophylactic repair of the aortic root was 51%, and 97%, respectively.
CONCLUSIONS: Survival in the Marfan's syndrome in the past 14 years seems satisfactory; with application of current guidelines, it has probably even improved. However, because of the high fatality rate in Marfan patients developing aortic root dissection, more extensive screening for Marfan's syndrome and a search for additional risk factors are desirable.

Entities:  

Mesh:

Year:  1999        PMID: 10490568      PMCID: PMC1760285          DOI: 10.1136/hrt.82.4.499

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

Review 2.  Marfan syndrome--current medical and genetic knowledge: how to treat and when.

Authors:  A H Child
Journal:  J Card Surg       Date:  1997 Mar-Apr       Impact factor: 1.620

3.  Repeated surgery for recurrent dissection of the aorta.

Authors:  J Bachet; C Brizard; B Goudot; G Dreyfus; G Teodori; D Brodaty; C Dubois; P Delentdeker; D Guilmet
Journal:  Eur J Cardiothorac Surg       Date:  1990       Impact factor: 4.191

4.  Life expectancy and causes of death in the Marfan syndrome.

Authors:  J L Murdoch; B A Walker; B L Halpern; J W Kuzma; V A McKusick
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

5.  A technique for complete replacement of the ascending aorta.

Authors:  H Bentall; A De Bono
Journal:  Thorax       Date:  1968-07       Impact factor: 9.139

6.  Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.

Authors:  D I Silverman; J Gray; M J Roman; A Bridges; K Burton; M Boxer; R B Devereux; P Tsipouras
Journal:  J Am Coll Cardiol       Date:  1995-10       Impact factor: 24.094

7.  Aortic root complications in Marfan's syndrome: identification of a lower risk group.

Authors:  M E Legget; T A Unger; C K O'Sullivan; T R Zwink; R L Bennett; P H Byers; C M Otto
Journal:  Heart       Date:  1996-04       Impact factor: 5.994

8.  Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation.

Authors:  L Rozendaal; M Groenink; M S Naeff; R C Hennekam; A A Hart; E E van der Wall; B J Mulder
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

9.  Life expectancy in the Marfan syndrome.

Authors:  D I Silverman; K J Burton; J Gray; M S Bosner; N T Kouchoukos; M J Roman; M Boxer; R B Devereux; P Tsipouras
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

10.  Determinants of echocardiographic aortic root size. The Framingham Heart Study.

Authors:  R S Vasan; M G Larson; D Levy
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

View more
  42 in total

Review 1.  Management of Marfan syndrome.

Authors:  John C S Dean
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

2.  Coexistence of anomalous origin of the coronary arteries and severe aortic regurgitation in Marfan syndrome.

Authors:  Dimitris P Papadopoulos; Ioannis Moyssakis; Vassilios E Votteas
Journal:  Clin Rheumatol       Date:  2005-11-03       Impact factor: 2.980

3.  Beyond the root: dilatation of the distal aorta in Marfan's syndrome.

Authors:  P M Engelfriet; E Boersma; J G P Tijssen; B J Bouma; B J M Mulder
Journal:  Heart       Date:  2006-02-17       Impact factor: 5.994

4.  Project report: adult congenital heart disease.

Authors:  B J M Mulder
Journal:  Neth Heart J       Date:  2002-11       Impact factor: 2.380

5.  Pregnancy and Marfan syndrome.

Authors:  Sorel Goland; Uri Elkayam
Journal:  Ann Cardiothorac Surg       Date:  2017-11

Review 6.  Marfan's syndrome and the heart.

Authors:  Alan Graham Stuart; Andrew Williams
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

7.  Echocardiography in Takotsubo cardiomyopathy; a useful approach?

Authors:  E E van der Wall; E R Holman; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-06       Impact factor: 2.357

8.  Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?

Authors:  E E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

9.  Cardiac magnetic resonance imaging in primary PCI: additional value?

Authors:  E E van der Wall; J J Bax; J W Jukema; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2009-05-26       Impact factor: 2.357

10.  Cardiovascular dynamics in ischemic cardiomyopathy during exercise.

Authors:  E E van der Wall; J J Bax; C A Swenne; P Steendijk; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.